<DOC>
	<DOCNO>NCT00607945</DOCNO>
	<brief_summary>The purpose study see dietary oil call conjugate linoleic acid , CLA , might useful combination diabetes medication . Some study show CLA modestly reduce body weight body fat . Our research idea take CLA reduce body weight body fat without interfere diabetes medication ' effect blood sugar .</brief_summary>
	<brief_title>Dietary Fatty Acids Complementary Therapy Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>The long term goal research develop effective complementary strategy aid management type 2 diabetes ( T2DM ) . Our central hypothesis CLA reduce body weight body fat mass administer concomitantly oral diabetes medication , The rationale study use CLA reduce body weight body fat people T2DM may improve efficacy longevity oral diabetes medication management T2DM . We plan test central hypothesis accomplish overall objective research pursue follow three specific aim . Specific Aim 1 : Determine ability CLA reduce body weight body fat mass people use oral diabetes medication management T2DM . Specific Aim 2 : Determine ability CLA modulate insulin sensitivity combine oral diabetes medication . Specific Aim 3 : Determine safety tolerability CLA combination oral diabetes medication .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Diagnosis type 2 diabetes mellitus HbA1c ≤ 9 % Overweight obese ( BMI ≥ 25 kg/m2 ≤ 45 kg/m2 ) Age ≥ 30 ≤ 70 year ( postmenopausal female ) Stable medical therapy past 3 month Stable body weight ( within ± 2 kg ) past 3 month Plans remain Columbus , OH metropolitan area least 1 year Substance abuse Current use prescription overthecounter medication supplement know affect body composition Current use prescription overthecounter medication supplement know interact thiazolidinediones ( TZDs ) Current previous diagnosis congestive heart failure Selfreport claustrophobia Abnormal liver function Impaired cognitive function Current previous diagnosis renal disease Gastrointestinal diseases disorder Current use hormone therapy , use within past 3 month Discontinuation diabetes medication</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>conjugate linoleic acid</keyword>
	<keyword>weight loss</keyword>
	<keyword>rosiglitazone</keyword>
	<keyword>glucose control</keyword>
	<keyword>insulin sensitivity</keyword>
</DOC>